Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA

Johan Askling,C.M. Fored,Lena Brandt,Eva Baecklund,L Bertilsson,Lars Cöster,P Geborek,L. Jacobsson,Staffan Lindblad,J Lysholm,Solbritt Rantapää-Dahlqvist,Tore Saxne,Nils Feltelius,L. Klareskog

Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA

2005

Johan Askling
C.M. Fored
Lena Brandt
Eva Baecklund
L Bertilsson
Lars Cöster
P Geborek
L. Jacobsson
Staffan Lindblad
J Lysholm
Solbritt Rantapää-Dahlqvist
Tore Saxne
Nils Feltelius
L. Klareskog

Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA

Keywords:

Physical therapy
Diabetes mellitus
Tumor necrosis factor alpha
Blockade
Medicine
Internal medicine
tnf blockade

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations